Drug Approval | March 10, 2023
Zydus receives final approval from the USFDA for Erythromycin Tablets
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
The company will engage with the agency to resolve the import alert at the earliest.
Subscribe To Our Newsletter & Stay Updated
